Data Collective IV GP, LLC
In its 13F for Q4 2024 (holdings as of December 31, 2024, filed February 14, 2025), Data Collective IV GP, LLC reported 6 stock positions worth $226.3 million. Its top holding was Oklo (OKLO) at 49.5% of the portfolio, followed by Recursion Pharmaceuticals-A (RXRX, 17.7%) and Evolv Technologies (EVLV, 16.9%). Compared with Q3 2024, it reduced 2. The biggest sale was Rocket Lab USA (RKLB, shares −53%).
- Most Recent 13F
- Q2 2026
- Location
- PALO ALTO, CA
- CIK
- 0001664974
- Portfolio Value
- $226.3M (Q4 2024)
- SEC Filing
- 0001104659-25-013451 ↗ filed Feb 14, 2025
Holdings Value
Holdings 6 stocks · $226.3M
| OKLO Oklo Inc. | 49.51% | 5,277,513 | $112.0M | Reduce -23.7% |
| RXRX Recursion Pharmaceuticals-A | 17.75% | 5,941,120 | $40.2M | No change |
| EVLV Evolv Technologies Holdings | 16.90% | 9,681,281 | $38.2M | No change |
| RKLB Rocket Lab USA Inc. | 15.51% | 1,377,943 | $35.1M | Reduce -53.0% |
| MIND MEDICINE MINDMED INC | 0.31% | 100,350 | $698K | No change |
| ROIV Roivant Sciences Ltd. | 0.02% | 3,875 | $46K | No change |
Portfolio Sells Q3 2024 → Q4 2024
Portfolio Buys Q3 2024 → Q4 2024
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 4 | $78.6M | EVLV, HQ, RXRX, DFTX |
| Q1 2026 | 4 | $55.9M | EVLV, RXRX, HQ, DFTX |
| Q4 2025 | 3 | $58.5M | EVLV, RXRX, MIND MEDICINE MINDMED INC |
| Q3 2025 | 4 | $68.0M | EVLV, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q2 2025 | 5 | $129.9M | EVLV, RKLB, RXRX, MIND MEDICINE MINDMED INC, ROIV |
| Q1 2025 | 5 | $86.9M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |
| Q4 2024 | 6 | $226.3M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q3 2024 | 6 | $163.5M | OKLO, EVLV, RXRX, RKLB, MIND MEDICINE MINDMED INC |
| Q2 2024 | 6 | $142.7M | OKLO, RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC |
| Q1 2024 | 5 | $115.3M | RXRX, EVLV, RKLB, MIND MEDICINE MINDMED INC, ROIV |